There are already more trials underway to better understand the promise of GLP-1 drugs in AUD, including one at the NIH
Most major insurance plans, possibly including UnitedHealthcare, Blue Cross Blue Shield, Medicaid, and Medicare, recognize weight loss medications for documented obesity or qualifying conditions
JoHelen McClain, a 72-year-old real estate agent from suburban Oklahoma City, had a simple goal when she started taking Wegovy in November of 2023
BPC-157: Healing the Lining Sometimes the problem is not the egg
Gastrointestinal side effectsincluding nausea and delayed gastric emptyingcould theoretically affect milk composition or infant tolerance if maternal GLP-1 levels were sufficiently high in milk
Each is studied for metabolic regulation and weight management, but they target different combinations of receptor pathways, which makes them suitable for different research questions